$TDOC

Teladoc Health, Inc. (TDOC): Results of Operations and Financial Condition

Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Teladoc Health Reports Second Quarter 2026 Results NEW YORK, July 29, 2026 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2026 (“Second Quarter 2026”). Unless otherwise note

Original reporting
Published Jul 29, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$TDOC
Bearish
high confidence
Mentioned
$TDOC
Relevance
8/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TDOCBearishMed
01

Why it matters

The key new decision-relevant item is management lowering the BetterHelp segment revenue outlook due to cash-pay pressure accelerating beyond prior assumptions, while Integrated Care remains a relative bright spot with margin strength and the Teladoc One launch.

02

Market read

Traders should focus on the segment outlook change and cash-pay vs insurance mix dynamics, as they directly affect near-term revenue expectations and margin trajectory.

03

What to watch

The filing notes insurance demand outpaced provider capacity and that Teladoc accelerated the nationwide insurance rollout ahead of plan; execution on capacity conversion could reduce the magnitude of the cash-pay drag over time.

Relevance 8/10Novelty 7/10Timing: after-hours following the Q2 2026 results 8-K (filed July 29, 2026)
alphai · Earnings readTDOC · Second Quarter 2026 · ended June 30, 2026

Second Quarter 2026 revenue of $606.9 million, down 4% year-over-year; net loss of $38.9 million, or $0.21 per share; and adjusted EBITDA of $65.7 million, down 5% year-over-year.

Mixed quarter

Integrated Care revenue increased 1% and its adjusted EBITDA margin was 16.5%, but consolidated revenue decreased 4%, BetterHelp revenue decreased 12%, adjusted EBITDA decreased 5%, free cash flow declined, and the company lowered its BetterHelp segment revenue outlook.

Revenue
$606.9 million
down 4% y/y
Integrated Care
$394.3 million
up 1% year-over-year y/y
EPS · GAAP
$0.21
(11)% y/y
Full Year 2026 and 3Q 2026 outlook
Full Year 2026: $2,362 - $2,447 million; 3Q 2026: $569 - $609 million

Key metrics

as reported
MetricValueq/qy/y
RevenueGAAP$606.9 milliondown 4%
Access fees revenueGAAP$474.2 milliondecreased 9%
Other revenueGAAP$132.7 millionincreased 23%
U.S. revenueGAAP$487.4 milliondecreased 6%
International revenueGAAP$119.6 millionincreased 7%
Net lossGAAP$38.9 million(19)%
Net loss per shareGAAP$0.21 per share(11)%
Adjusted EBITDAnon-GAAP$65.7 milliondown 5%
Integrated Care segment adjusted EBITDAnon-GAAPincrease of $7.8 million
BetterHelp segment adjusted EBITDAnon-GAAPdecrease of $11.4 million
Cash flow from operationsother$64.7 million
Capital expenditures and capitalized software development costsother$28.9 million
Free cash flowother$35.7 million
Six-month revenueGAAP$1,220.8 milliondecreased 3%
Six-month net lossGAAP$102.7 million18%
Six-month net loss per shareGAAP$0.57 per share21%
Six-month adjusted EBITDAnon-GAAP$123.9 milliondecreased 3%
Six-month cash flow from operationsother$74.2 million
Six-month capital expenditures and capitalized software development costsother$64.7 million
Six-month free cash flowother$9.4 million

Segments

SegmentRevenueq/qy/y
Integrated CareAdjusted EBITDA margin of 16.5%; the company stated that revenue growth and adjusted EBITDA margin were above the midpoint of its guidance ranges.$394.3 millionup 1% year-over-year
BetterHelpAdjusted EBITDA margin of 0.2%; insurance revenue came in near the high end of expectations, while cash pay revenue pressure accelerated in late May and June.$212.6 milliondown 12% year-over-year
Integrated Care, first six months of 2026Segment adjusted EBITDA increased $13.7 million in the first six months of 2026.$789.8 millionincreased 1%
BetterHelp, first six months of 2026Segment adjusted EBITDA decreased $17.2 million in the first six months of 2026.$431.0 milliondecreased 10%

Full Year 2026 and 3Q 2026 outlook

  • RevenueFull Year 2026: $2,362 - $2,447 million; 3Q 2026: $569 - $609 million
  • NoteFull Year 2026 Adjusted EBITDA: $271 - $303 million
  • NoteFull Year 2026 Net loss per share: ($1.00) - ($0.75)
  • NoteFull Year 2026 Free Cash Flow: $130 - $170 million
  • NoteFull Year 2026 U.S. Integrated Care Members: 98.5 - 100.5 million
  • NoteFull Year 2026 Integrated Care Revenue growth percentage (year-over-year): 0.8% - 2.4%
  • NoteFull Year 2026 Integrated Care Adjusted EBITDA margin: 15.6% - 16.4%
  • NoteFull Year 2026 BetterHelp Revenue growth percentage (year-over-year): (19.0%) - (12.7%)
  • NoteFull Year 2026 BetterHelp Adjusted EBITDA margin: 3.0% - 4.6%
  • Note3Q 2026 Adjusted EBITDA: $62 - $74 million
  • Note3Q 2026 Net loss per share: ($0.30) - ($0.20)
  • Note3Q 2026 U.S. Integrated Care Members: 99.0 - 100.5 million
  • Note3Q 2026 Integrated Care Revenue growth percentage (year-over-year): 0.0% - 3.0%
  • Note3Q 2026 Integrated Care Adjusted EBITDA margin: 15.7% - 17.2%
  • Note3Q 2026 BetterHelp Revenue growth percentage (year-over-year): (24.2%) - (12.3%)
  • Note3Q 2026 BetterHelp Adjusted EBITDA margin: 0.5% - 2.5%

What drove it

  • Integrated Care segment revenue increased 1% to $394.3 million.
  • Other revenue increased 23% to $132.7 million.
  • International revenue increased 7% to $119.6 million.
  • The company launched Teladoc One, its new connected care model for the U.S. market.
  • BetterHelp insurance revenue came in near the high end of expectations.
  • The company accelerated the nationwide insurance rollout ahead of plan.

Concerns

  • Consolidated revenue decreased 4% to $606.9 million.
  • Access fees revenue decreased 9% to $474.2 million.
  • U.S. revenue decreased 6% to $487.4 million.
  • BetterHelp segment revenue decreased 12% to $212.6 million.
  • BetterHelp cash pay revenue pressure accelerated further in late May and into June.
  • Demand for insurance-covered services outpaced available provider capacity, limiting conversion into sessions and revenue.
  • Adjusted EBITDA decreased 5% to $65.7 million.
  • Free cash flow declined to $35.7 million from $61.2 million.

What to watch

  • BetterHelp cash pay revenue assumptions and the revised full-year BetterHelp revenue growth range of (19.0%) - (12.7%).
  • The scaling of provider capacity for insurance-covered BetterHelp services.
  • BetterHelp adjusted EBITDA margin guidance of 0.5% - 2.5% for 3Q 2026 and 3.0% - 4.6% for Full Year 2026.
  • Integrated Care revenue growth and adjusted EBITDA margin against the 3Q 2026 outlook ranges.
  • Free cash flow against the Full Year 2026 outlook of $130 - $170 million.

Balance sheet and cash flow

  • Cash flow from operations was $64.7 million in Second Quarter 2026, compared to $91.4 million in Second Quarter 2025.
  • Capital expenditures and capitalized software development costs were $28.9 million in Second Quarter 2026, compared to $30.2 million in Second Quarter 2025.
  • Free cash flow was $35.7 million in Second Quarter 2026, compared to $61.2 million in Second Quarter 2025.
  • Cash flow from operations was $74.2 million in the first six months of 2026, compared to $107.4 million in the first six months of 2025.
  • Free cash flow was $9.4 million in the first six months of 2026, compared to $45.5 million in the first six months of 2025.

Analysis

Teladoc Health reported a weaker consolidated second quarter, with revenue decreasing 4% to $606.9 million and adjusted EBITDA decreasing 5% to $65.7 million. The GAAP net loss increased to $38.9 million from $32.7 million, while net loss per share increased to $0.21 from $0.19. Revenue pressure was concentrated in access fees, which decreased 9% to $474.2 million, and in U.S. revenue, which decreased 6% to $487.4 million. Other revenue increased 23% to $132.7 million and International revenue increased 7% to $119.6 million.

The two segments continued to diverge. Integrated Care revenue increased 1% to $394.3 million and delivered a 16.5% adjusted EBITDA margin. Management said both its revenue growth and adjusted EBITDA margin were above the midpoint of their guidance ranges, and cited the launch of Teladoc One in the U.S. market. BetterHelp revenue decreased 12% to $212.6 million and its adjusted EBITDA margin was 0.2%. The $7.8 million increase in Integrated Care adjusted EBITDA was more than offset by an $11.4 million decrease in BetterHelp adjusted EBITDA.

BetterHelp's demand and capacity dynamics drove the guidance change. Management said insurance revenue was near the high end of expectations, but cash pay pressure accelerated in late May and June. Demand for insurance-covered services exceeded available provider capacity, limiting conversion into sessions and revenue. The company accelerated its nationwide insurance rollout ahead of plan, continues to expect 2026 insurance revenue within its previously communicated range, and lowered the BetterHelp segment revenue outlook to incorporate updated cash pay assumptions and prioritization of the insurance market.

Cash generation also declined in the quarter. Cash flow from operations was $64.7 million compared with $91.4 million, while capex was $28.9 million compared with $30.2 million and free cash flow was $35.7 million compared with $61.2 million. For the first six months, revenue decreased 3% to $1,220.8 million, adjusted EBITDA decreased 3% to $123.9 million, and free cash flow was $9.4 million compared with $45.5 million. The full-year outlook calls for revenue of $2,362 - $2,447 million, adjusted EBITDA of $271 - $303 million, and free cash flow of $130 - $170 million, while the third-quarter outlook calls for revenue of $569 - $609 million and adjusted EBITDA of $62 - $74 million.

Management, verbatim

We continue to make progress on the priorities we believe are most important to the long-term success of Teladoc Health. Our second-quarter results were within our guidance ranges on a consolidated basis and reflected distinct dynamics across our two segments.

Chuck Divita, Chief Executive Officer of Teladoc Health

In the BetterHelp segment, insurance revenue came in near the high end of our expectations. However, pressure on cash pay revenue accelerated further in late May and into June, beyond the assumptions underlying our prior outlook.

Chuck Divita, Chief Executive Officer of Teladoc Health

Not in the filing

stated, not guessed
  • GAAP gross margin
  • GAAP operating income or loss
  • GAAP operating expenses
  • Cash balance
  • Debt balance
  • Share repurchases
  • Dividends
  • Previous-release outlook for metric-by-metric comparison
  • Quarter-over-quarter comparisons

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC 8-K (Item 2.02) with Exhibit 99.1 reporting Teladoc’s Q2 2026 results for the three months ended June 30, 2026.

Company-level read

Ticker impact

$TDOCBearishHigh confidence
Context

Teladoc reported Q2 2026 revenue of $606.9M (down 4% YoY) and lowered BetterHelp revenue outlook due to faster cash-pay pressure.

Expected impact

Likely bearish bias for TDOC into the next earnings cycle as investors reprice BetterHelp revenue trajectory and cash conversion.

Evidence & confidence

The filing discloses segment-level revenue declines (BetterHelp -12% YoY) and management commentary that cash-pay pressure accelerated beyond prior assumptions, prompting a lowered segment outlook.

Market effects

Virtual care and telehealth platforms may face heightened sensitivity to payer mix and cash-pay demand elasticity, reinforcing focus on segment economics.

U.S. revenue declined 6% YoY while International rose 7%, suggesting investors may differentiate U.S. payer dynamics from ex-U.S. growth.

Limited direct global read-across beyond investor scrutiny of reimbursement mix and provider capacity constraints.

Counterpoint

Integrated Care delivered revenue growth and adjusted EBITDA margin above the midpoint of guidance, which could stabilize consolidated results if BetterHelp scaling improves.

Key entities

  • Teladoc Health, Inc.

    Reported Q2 2026 financial results and provided segment commentary, including a lowered BetterHelp revenue outlook.

  • BetterHelp segment

    Revenue down 12% YoY to $212.6M; cash-pay pressure accelerated and outlook was lowered.

  • Integrated Care segment

    Revenue up 1% YoY to $394.3M; adjusted EBITDA margin 16.5% and Teladoc One launch mentioned.

Every TDOC earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky said it is investigating Teladoc Health (NYSE: TDOC) after the company reported Q2 2026 revenue of $606.9 million, below consensus of $615 million to $628 million, and cut full-year 2026 revenue guidance to $2.36 billion to $2.45 billion. The notice cites prior guidance changes and comments about BetterHelp cash pay user declines and insurance capacity.

$METAMed

Futures Rise As Oil Drops, Bond Selling Slows, Meta Tumbles And Microsoft Soars

US stock index futures rose in premarket after a prior selloff tied to Fed-related concerns. Microsoft shares jumped about 9% after cloud growth accelerated, while Meta fell about 8% after revenue guidance disappointed and free cash flow was weak. Bond selling slowed and 30-year yields hit a two-decade high near 5.22%. Several other earnings moves were reported, including MO, CVNA, CMG, and QCOM.